Medical device and MedTech insights, news, tips and more

Massive Medtronic Pacemaker Recall is Class I Says FDA

February 18, 2019

fda

The FDA has slapped the most serious designation on a recall of approximately 156,957 Medtronic dual-chamber pacemakers.

The Fridley, Minn.-based company issued a recall in January on pacemakers with model names Adapta, Versa, Sensia, Relia, Attesta, Sphera, and Vitatron due to a software error that can result in a lack of pacing.

Patients and physicians cannot predict whether and when this software error might occur, according to FDA, which gave the recall a Class I designation, the most serious type of recall. A lack of pacing could result in patients experiencing slow heart beating, low blood pressure, and symptoms such as light-headedness, fainting, and even death.

The company said two patient experienced a pause in pacemaking, but that no deaths were reported.

Medtronic said the root cause for the issue is related to a design change to an integrated circuit in a subset of devices that were distributed between March 10, 2017, and January 7, 2019. The recall includes 13,440 devices distributed in the U.S.

See Full Story at the Source: FDA gives massive Medtronic recall Class I designation – MassDevice


Written by: Nancy Crotti


A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.